GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...

UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...

“They sort of help with neutralizing that excess, stomach acid production,” says pharmacist Brianna Pallot. “Heartburn is ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

This can play a role in the development of heartburn or make it worse. A healthcare provider may advise surgery if GERD doesn't go away with lifestyle changes or medications. Some therapies use an ...

Dr Ahmed, a GP based in the UK, took to TikTok to issue the warning, saying: "I bet the vast majority of you have even been ...

Consult your healthcare professional before taking or discontinuing any drug or commencing any course ... within 1 hour before or 2 hours after your antacid. Your doctor may want to check your ...

Thanks largely to news of a crucial legal settlement, GSK ( GSK 5.84%) was one of the better-performing big pharma stocks on Wednesday. Relieved investors showed their appreciation by collectively ...

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.

The product reduces the amount of acid the stomach makes, and was a best-seller in the UK and US in the early 1980s in treating indigestion, heartburn and acid reflux. It was the first drug to ...

Lawsuits against the companies began piling up in both state and federal courts after the US Food and Drug Administration in ...